Hong Kong, 6 May 2026 – Sisram Medical Ltd. released its Monthly Return for Equity Issuers, confirming that no changes occurred in authorised, issued or treasury shares during April 2026.

Authorised Share Capital • Authorised share count remained at 1.00 billion ordinary shares, each with a par value of ILS 0.01, keeping total authorised capital unchanged at ILS 10.00 million.

Issued Shares • Issued shares stood at 468.34 million, identical to the previous month. • The company held no treasury shares, leaving total issued shares unchanged at 468.34 million.

Public Float • Sisram Medical affirmed compliance with the Main Board’s Initial Prescribed Threshold, maintaining at least 25 % of issued shares in public hands as at 30 April 2026.

No activity was reported under share option schemes, warrants, convertibles or other share-related arrangements. The filing was signed by Company Secretary Qianli Fang.